Results 71 to 80 of about 1,174,103 (294)
Study of spread spectrum multiple access systems for satellite communications with overlay on current services [PDF]
The feasibility of using spread spectrum techniques to provide a low-cost multiple access system for a very large number of low data terminals was investigated.
Ha, Tri T., Pratt, Timothy
core +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Key technologies of smart home network based on G.hn
Dianxin kexue, 2017 In the future smart home,intelligent network high-speed home networking become the trend.Based on this,firstly the modulation and bandwidth of G.hn protocol and the current frequency coaxial cable usage were analyzed.Then the key technology of the G.hn ...
Dongdi XIAO, Wenda YING, Tao GUO
doaj
Wide spread spectrum watermarking with side information and interference cancellation
, 2008 Nowadays, a popular method used for additive watermarking is wide spread spectrum. It consists in adding a spread signal into the host document. This signal is obtained by the sum of a set of carrier vectors, which are modulated by the bits to be ...
Guelvouit, Gaëtan Le, Pateux, Stéphane
core +2 more sources
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Molecular Oncology, EarlyView.Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Molecular Oncology, EarlyView.Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
Molecular Oncology, EarlyView.p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
Coded spread spectrum digital transmission system design study [PDF]
Results are presented of a comprehensive study of the performance of Viterbi-decoded convolutional codes in the presence of nonideal carrier tracking and bit synchronization.
Heller, J. A. +2 more
core +1 more source
Molecular Oncology, EarlyView.This work identified serum proteins associated with pancreatic epithelial neoplasms (PanINs) and early‐stage PDAC. Proteomics screens assessed genetically engineered mice with abundant PanINs, KPC mice (Lox‐STOP‐Lox‐KrasG12D/+ Lox‐STOP‐Lox‐Trp53R172H/+ Pdx1‐Cre) before PDAC development and also early‐stage PDAC patients (n = 31), compared to benign ...
Hannah Mearns +10 more
wiley +1 more source
IRS-TR 12001: Spectral Pointing-Induced Throughput Error and Spectral Shape in Short-Low Order 1 [PDF]
, 2012 We investigate how the shape of a spectrum in the Short-Low module on the IRS varies with its overall throughput, which depends on how well centered a source is in the spectroscopic slit.
Ludovici, D., Sloan, G. C.
core